Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
โ Scribed by Kitahata, Mari M.; Gange, Stephen J.; Abraham, Alison G.; Merriman, Barry; Saag, Michael S.; Justice, Amy C.; Hogg, Robert S.; Deeks, Steven G.; Eron, Joseph J.; Brooks, John T.; Rourke, Sean B.; Gill, M. John; Bosch, Ronald J.; Martin, Jeffrey N.; Klein, Marina B.; Jacobson, Lisa P.; Rodriguez, Benigno; Sterling, Timothy R.; Kirk, Gregory D.; Napravnik, Sonia; Rachlis, Anita R.; Calzavara, Liviana M.; Horberg, Michael A.; Silverberg, Michael J.; Gebo, Kelly A.; Goedert, James J.; Benson, Constance A.; Collier, Ann C.; Van Rompaey, Stephen E.; Crane, Heidi M.; McKaig, Rosemary G.; Lau, Bryan; Freeman, Aimee M.; Moore, Richard D.
- Book ID
- 120548997
- Publisher
- Massachusetts Medical Society
- Year
- 2009
- Tongue
- English
- Weight
- 279 KB
- Volume
- 360
- Category
- Article
- ISSN
- 0096-6762
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background For antiretroviral therapy (ART) naive human immunodeficiency virus (HIV) infected adults suffering from tuberculosis (TB), there is uncertainty about the optimal time to initiate highly active antiretroviral therapy (HAART) after starting antituberculosis treatment (ATT), in order to